1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
83rd OREGON LEGISLATIVE ASSEMBLY--2025 Regular Session
SENATE AMENDMENTS TO
SENATE BILL 451
By COMMITTEE ON HEALTH CARE
March 13
On page 1 of the printed bill, delete lines 5 through 26 and insert:
“SECTION 2.(1) As used in this section:
“(a)(A) ‘Cervical cancer screening’ means health care services or products provided to
an individual without apparent symptoms of an illness, injury or disease as recommended by
the United States Preventive Services Task Force as Grade A or B or as recommended by
the Health Resources and Services Administration’s guidelines, for the purpose of detecting
the presence of cervical cancer or precancerous lesions.
“(B) ‘Cervical cancer screening’ does not include services that occur primarily for the
treatment of diagnosed cervical cancer.
“(b)(A) ‘Follow-up examination’ means additional cervical cancer examinations used to
evaluate an abnormality seen or suspected by a cervical cancer screening.
“(B) ‘Follow-up examination’ does not include services that occur primarily for the
treatment of diagnosed cervical cancer.
“(2) Except as provided in ORS 742.008, a carrier offering a group health benefit plan or
an individual health benefit plan in this state that reimburses the cost of cervical cancer
screenings may not impose deductibles, coinsurance, copayments or other out-of-pocket
costs on the coverage of medically necessary:
“(a) Cervical cancer screenings; and
“(b) Follow-up examinations, regardless of whether different samples from the prior
cervical cancer screening are used or the follow-up examination is performed on a different
date than the cervical cancer screening. Follow-up examinations include human
papillomavirus examinations with typing, cytology, dual stain or colposcopy with biopsy. ”.
LC 115/SB 451-1